Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicera Therapeutics AB | 5,256,113 | net | 11 Mar 2025 | tx 7+5,256,113 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 50,000 | 1.85 SEK | first after silence |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 12,345 | 16.20 SEK | first after silence |
| 07 Jul 2021 | OTHER | Elicera Therapeutics AB | 2,583,334 | 0.00 SEK | |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 12,100 | 4.30 SEK | |
| 10 Jun 2021 | LENDING | Elicera Therapeutics AB | 2,583,334 | 0.00 SEK | |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 7,500 | 8.00 SEK | |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 7,500 | 0.00 SEK | deriv |
2 purchases reported after at least 12 months of silence — most recent on 11 Mar 2025.